LSL LSL Pharma Group Inc.

0.2272USD0.3250 CAD · TSXV-2.99%Mkt Cap: 28.79M USDP/E: —

LSL Pharma Group Inc. develops, manufactures, and commercializes sterile pharmaceutical products, cosmetic products, and natural health products in Canada, the United States, and internationally. It offers dietary supple…

Key Statistics

Company
Market Cap28.79M USD
Enterprise Value63.48M USD
Revenue (TTM)29.24M USD
Gross Profit3.57M USD
Net Income (TTM)-1.97M USD
Revenue/Share0.24 USD
Last Price0.2272 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees252
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA50190N1042
Valuation
P/E (Trailing)—
P/E (Forward)16.25
PEG—
EV/EBITDA-56.27
EV/Revenue2.17
P/S0.98
P/B1.88
EPS (TTM)-0.03 USD
EPS (Forward)0.01 USD
52W Range
0.181822% of range0.3915
52W High0.3915 USD
52W Low0.1818 USD
Profitability
Gross Margin17.75%
Oper. Margin-10.19%
EBITDA Margin-3.86%
Profit Margin-9.81%
ROE-10.46%
ROA-3.77%
ROIC-3.49%
ROCE-3.59%
Growth
Revenue Growth102.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.71M USD
CapEx (TTM)3.47M USD
FCF Margin-27.09%
FCF Yield-27.51%
Net Debt34.69M USD
Net Debt/EBITDA-30.75
Net Debt/FCF—
Balance Sheet
Debt/Equity1.42
Current Ratio1.16
Quick Ratio0.38
Book Value/Sh0.12 USD
Cash/Share0.0056 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)0.4194 USD
Upside (mean)+84.6%
Target Range0.4194 USD – 0.4194 USD
# Analysts1
Ownership
Shares Out.126.73M
Float95.70M
Insiders24.64%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short320
Short (prev mo.)682
Technical
SMA 500.2143 (+6.0%)
SMA 2000.2521 (-9.9%)
Beta-0.41
S&P 52W Chg12.00%
Avg Vol (30d)34.19K
Avg Vol (10d)25.91K
Technical Indicators
RSI (14)56.5
MACD0.0045
MACD Signal0.0008
MACD Hist.+0.0037
BB Upper0.2354 USD
BB Middle0.2153 USD
BB Lower0.1952 USD
BB Width18.65%
ATR (14)0.0108 USD
Vol Ratio (20d)0.50x

About LSL Pharma Group (CVE: LSL)

›

LSL Pharma Group (CVE: LSL) is listed on the TSX Venture Exchange, where its shares trade in CAD. It belongs to the Drug Manufacturers - Specialty & Generic industry, part of the Healthcare sector, and reports about 252 employees.

The shares were at 0.3250 CAD on 19 November 2026, down 5.8% over 52 weeks. Its 52-week range is 0.2600 CAD to 0.5600 CAD: the price is 42.0% below the high and 25.0% above the low.

Its market capitalisation is 41.19M CAD.

LSL Pharma Group reports return on equity of -10.5%, an operating margin of -10.2% and revenue up 102.7% year over year.

Its debt exceeds its cash by 49.63M CAD, a debt-to-equity ratio of 1.42. Its Piotroski F-score is 3 out of 9, a weak reading of its financial health. One analyst covers the stock, with an average rating of Strong Buy; their mean price target of 0.6000 CAD is 84.6% above the current price.